September 21st, 2014
Parkinson’s Drug Recall
Parkinson’s Drug Recall
September 4, 2014
Nearly 4,000 bottles of a Parkinson’s combination drug are being pulled from shelves, according to the U.S. Food and Drug Administration.
The U.S. nationwide recall is due to what may potentially be ‘superpotent’ carbidopa/levodopatablets.
This recall comes on the heels of a recall in April and June for the Israeli generic drug maker.
References:
1. Teva Recalling ‘Superpotent’ Drug for Parkinson’s Disease. FDANews. 2014 Aug 27.
2. Palmer E. Teva recalls Parkinson's disease drug because it may be 'superpotent'. Fierce Pharma. 2014 Aug 26.
PLN Topics:
Medication Errors
RELATED ARTICLES
Baxter Recalls Potassium Chloride Injection
Heparin Recall Due to Human Hair
Warfarin Sodium Tablets Recall
FDA Issues Reminder to Avoid Products from Texas Compounder
Compounding Pharmacy Recall
- August 18th, 2012
What would you do if you saw someone collapse?Read - September 21st, 2014
Antibiotic Recall Due to Particulate MatterRead - September 9th, 2014
Wockhardt Recalls Blood Pressure DrugRead - March 30th, 2014
What is HIGH BLOOD PRESSURE (HYPERTENSION)Read - December 4th, 2014
Diabetes: Can You Hear Me Now?Read
Geriatric Nutrition
Without good nutrition, positive drug therapy outcomes are very difficult to obtain, For the best in Geriatric Nutritional Information
Find out more Optima SolutionsContinuing Education
Each month we will post an analysis of specific aspects of government long-term healthcare regulations.
Find out more